1
|
Giang LM, Trang NT, Hoe HD, Anh NH, Thuy DTT, Bart G. "If they get out of drug rehab centers, they're on their own": Opportunities and challenges for people released from compulsory drug rehabilitation centers to communities in Vietnam. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2024; 128:104443. [PMID: 38743963 PMCID: PMC11213659 DOI: 10.1016/j.drugpo.2024.104443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 04/21/2024] [Accepted: 04/21/2024] [Indexed: 05/16/2024]
Abstract
INTRODUCTION Compulsory drug rehabilitation is a major governmental response to illicit drug use in Vietnam and other countries in Asia. Long-term compulsory rehabilitation is associated with negative health, social and economic outcomes. The transition to community-based services for people released from compulsory drug rehabilitation has been problematic not only in Vietnam. This study utilized the WHO Health System Building Blocks Framework to examine the opportunities and challenges for people with substance use disorders (SUD) who are released from compulsory drug rehabilitation back into the community. METHODS Between October 2021 and August 2022, we interviewed people with SUD who had recently returned from or were preparing to leave compulsory drug rehabilitation (n = 25), their family members (n = 20) and professionals working in the field of drug rehabilitation (n = 28) across three cities in Vietnam. Additionally, we conducted a review of policy documents to complement the interview data. RESULTS The study identified opportunities and challenges within Vietnam's drug rehabilitation system concerning leadership and governance, financing, workforce, information systems and service delivery for people with SUD. Key opportunities include a legal framework that emphasizes community-based support for people with SUD, a government-funded national network of lay social workers, and ongoing efforts to connect people to community-based services. We found significant challenges caused by the lack of clear instructions for implementing supportive policies, inadequate funding for community-based services, persisting stigma from providers towards people with SUD and unavailability of community-based drug treatment other than methadone. CONCLUSION Vietnam continues with compulsory drug rehabilitation yet endorses recovery-oriented policies to address substance use issues. Substantial challenges hinder the effective implementation of these policies. Our study recommends reinforcing existing policies and enhancing recovery-oriented community-based services by improving the quality of data collection, building capacity of lay social workers who facilitate linkages to services and expanding community-based drug treatment options.
Collapse
Affiliation(s)
- Le Minh Giang
- Center for Training and Research on Substance Use & HIV, Hanoi Medical University, Vietnam
| | - Nguyen Thu Trang
- Center for Training and Research on Substance Use & HIV, Hanoi Medical University, Vietnam.
| | - Han Dinh Hoe
- Center for Training and Research on Substance Use & HIV, Hanoi Medical University, Vietnam
| | - Nguyen Huu Anh
- Center for Training and Research on Substance Use & HIV, Hanoi Medical University, Vietnam
| | - Dinh Thi Thanh Thuy
- Center for Training and Research on Substance Use & HIV, Hanoi Medical University, Vietnam
| | - Gavin Bart
- Division of Addiction Medicine, Hennepin Healthcare and University of Minnesota Medical School, United States
| |
Collapse
|
2
|
Cousien A, Donadille C, Madrid LB, Maradan G, Jauffret-Roustide M, Lalanne L, Auriacombe M, Roux P, Boyer S. Cost-effectiveness of drug consumption rooms in France: a modelling study. BMC Public Health 2024; 24:1426. [PMID: 38807111 PMCID: PMC11135012 DOI: 10.1186/s12889-024-18909-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Accepted: 05/21/2024] [Indexed: 05/30/2024] Open
Abstract
BACKGROUND People who inject drugs (PWID) experience many health problems which result in a heavy economic and public health burden. To tackle this issue, France opened two drug consumption rooms (DCRs) in Paris and Strasbourg in 2016. This study assessed their long-term health benefits, costs and cost-effectiveness. METHODS We developed a model to simulate two fictive cohorts for each city (n=2,997 in Paris and n=2,971 in Strasbourg) i) PWID attending a DCR over the period 2016-2026, ii) PWID attending no DCR. The model accounted for HIV and HCV infections, skin abscesses and related infective endocarditis, drug overdoses and emergency department visits. We estimated the number of health events and associated costs over 2016-2026, the lifetime number of quality-adjusted life-years (QALYs) and costs, and the incremental cost-effectiveness ratio (ICER). RESULTS The numbers of abscesses and associated infective endocarditis, drug overdoses, and emergency department visits decreased significantly in PWID attending DCRs (-77%, -69%, and -65%, respectively) but the impact on HIV and HCV infections was modest (-11% and -6%, respectively). This resulted in savings of €6.6 (Paris) and €5.8 (Strasbourg) millions of medical costs. The ICER of DRCs was €30,600/QALY (Paris) and €9,200/QALY (Strasbourg). In scenario analysis where drug consumption spaces are implemented inside existing harm reduction structures, these ICERs decreased to €21,400/QALY and €2,500/QALY, respectively. CONCLUSIONS Our findings show that DCRs are highly effective and efficient to prevent harms in PWID in France, and advocate extending this intervention to other cities by adding drug consumption spaces inside existing harm reduction centers.
Collapse
Affiliation(s)
- Anthony Cousien
- Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, F-75018, Paris, France.
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
| | - Cécile Donadille
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - Laélia Briand Madrid
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - Gwenaëlle Maradan
- ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - Marie Jauffret-Roustide
- Centre d'Etudes des Mouvements Sociaux, Inserm U1276, CNRS UMR 8044, EHESS, Paris, France
- British Columbia Center on Substance Use (BCCSU), Vancouver, Canada
- Baldy Center on Law and Social Policy, Buffalo University, New York, USA
- Institut universitaire sur les dépendances, Université de Sherbrooke, Montréal, Québec, Canada
| | - Laurence Lalanne
- UMR 1329, Team Addictions, Centre de recherche en biomédecine de Strasbourg, Department of addiction medicine, University hospital of Strasbourg, Strasbourg, France
| | - Marc Auriacombe
- UMR 6033, Bordeaux University, SANPSY, CNRS, Bordeaux, France
| | - Perrine Roux
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - Sylvie Boyer
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| |
Collapse
|
3
|
Rosen JG, Thompson E, Tardif J, Collins AB, Marshall BDL, Park JN. "Make yourself un-NIMBY-able": stakeholder perspectives on strategies to mobilize public and political support for overdose prevention centers in the United States of America. Harm Reduct J 2024; 21:40. [PMID: 38355641 PMCID: PMC10868085 DOI: 10.1186/s12954-024-00955-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Accepted: 02/03/2024] [Indexed: 02/16/2024] Open
Abstract
BACKGROUND Overdose prevention centers (OPCs), also known as supervised injection facilities and safe consumption sites, are evidenced-based interventions for preventing overdose deaths and drug-related morbidities. The pathways to legalizing OPCs in the USA have confronted multiple social, political, and legal obstacles. We conducted a multi-site, qualitative study to explore heterogeneities in these pathways in four jurisdictions, as well as to understand stakeholder perspectives on valuable strategies for galvanizing political and public support for OPCs. METHODS From July 2022 to February 2023, we conducted 17 semi-structured, in-depth interviews with OPC policymakers, service providers, advocates, and researchers from California, New York City, Philadelphia, and Rhode Island, where efforts have been undertaken to authorize OPCs. Using inductive thematic analysis, we identified and compared contextually relevant, salient approaches for increasing support for OPCs. RESULTS Participants described several strategies clustering around five distinct domains: (1) embedding OPC advocacy into broader overdose prevention coalitions to shape policy dialogs; (2) building rapport with a plurality of powerbrokers (e.g., lawmakers, health departments, law enforcement) who could amplify the impact of OPC advocacy; (3) emphasizing specific benefits of OPCs to different audiences in different contexts; (4) leveraging relationships with frontline workers (e.g., emergency medicine and substance use treatment providers) to challenge OPC opposition, including 'NIMBY-ism,' and misinformation; and (5) prioritizing transparency in OPC decision-making to foster public trust. CONCLUSION While tailored to the specific socio-political context of each locality, multiple OPC advocacy strategies have been deployed to cultivate support for OPCs in the USA. Advocacy strategies that are multi-pronged, leverage partnerships with stakeholders at multiple levels, and tailor communications to different audiences and settings could yield the greatest impact in increasing support for, and diffusing opposition to, future OPC implementation.
Collapse
Affiliation(s)
- Joseph G Rosen
- Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe Street, Room E5031, Baltimore, MD, 21205, USA.
| | - Erin Thompson
- Harm Reduction Innovation Lab, Rhode Island Hospital, 1125 North Main Street, Providence, RI, 02904, USA
| | - Jessica Tardif
- Harm Reduction Innovation Lab, Rhode Island Hospital, 1125 North Main Street, Providence, RI, 02904, USA
| | - Alexandra B Collins
- Department of Epidemiology, School of Public Health, Brown University, 121 South Main Street, Providence, RI, 02903, USA
| | - Brandon D L Marshall
- Department of Epidemiology, School of Public Health, Brown University, 121 South Main Street, Providence, RI, 02903, USA
| | - Ju Nyeong Park
- Harm Reduction Innovation Lab, Rhode Island Hospital, 1125 North Main Street, Providence, RI, 02904, USA
- Department of Epidemiology, School of Public Health, Brown University, 121 South Main Street, Providence, RI, 02903, USA
- Department of General Internal Medicine, Warren Alpert Medical School, Brown University, 593 Eddy Street, Providence, RI, 02903, USA
| |
Collapse
|
4
|
Falzon D, Carver H, Masterton W, Wallace B, Sumnall H, Measham F, Craik V, Gittins R, Aston EV, Watson K, Hunter C, Priyadarshi S, Parkes T. Planning and implementing community-based drug checking services in Scotland: a qualitative exploration using the consolidated framework for implementation research. Subst Abuse Treat Prev Policy 2024; 19:7. [PMID: 38233933 PMCID: PMC10795311 DOI: 10.1186/s13011-023-00590-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Accepted: 12/31/2023] [Indexed: 01/19/2024] Open
Abstract
BACKGROUND Drug checking services (DCS) provide harm reduction support and advice to individuals based on chemical analysis of submitted substances of concern. Whilst there are currently no DCS in Scotland, community-based services are being planned in three cities. METHODS In this paper, we report qualitative findings based on interviews with 43 participants, focused on perceptions of DCS and their implementation. Participants were relevant professionals, those with experience of drug use, and family members of those with experience of drug use. The Consolidated Framework for Implementation Research (CFIR) was used to inform data collection and analysis. We report findings under nine constructs/themes across the five CFIR domains. RESULTS Participants noted the importance of DCS being implemented in low-threshold, trusted services with a harm reduction ethos, and outlined a range of further service design considerations such as speed of testing, and information provided through the analysis process. In relation to the 'inner setting', a key finding related to the potential value of leveraging existing resources in order to expand both reach and effectiveness of drug trend communication. The approach of local and national police to DCS, and the attitudes of the public and local community, were described as important external factors which could influence the success (or otherwise) of implementation. Bringing together a range of stakeholders in dialogue and developing tailored communication strategies were seen as ways to build support for DCS. Overall, we found high levels of support and perceived need for DCS amongst all stakeholder groups. CONCLUSIONS Our findings present initial implementation considerations for Scotland which could be further explored as DCS are operationalised. Further, our focus on implementation contexts is relevant to research on DCS more generally, given the minimal consideration of such issues in the literature.
Collapse
Affiliation(s)
- Danilo Falzon
- Faculty of Social Sciences, University of Stirling, FK9 4LA, Stirling, UK.
| | - Hannah Carver
- Faculty of Social Sciences, University of Stirling, FK9 4LA, Stirling, UK
| | - Wendy Masterton
- Faculty of Social Sciences, University of Stirling, FK9 4LA, Stirling, UK
| | - Bruce Wallace
- Canadian Institute for Substance Use Research, University of Victoria, BCV8P 5C2, Victoria, Canada
| | - Harry Sumnall
- School of Psychology, Faculty of Health, Liverpool John Moores University, L2 2QP, Liverpool, UK
| | - Fiona Measham
- Department of Sociology, Social Policy and Criminology, University of Liverpool, L69 7ZR, Liverpool, UK
- The Loop, Registered Charity, M13 9PL, Manchester, UK
| | | | | | - Elizabeth V Aston
- School of Applied Sciences, Edinburgh Napier University, EH11 4BN, Edinburgh, UK
| | - Kira Watson
- Scottish Ambulance Service, EH12 9EB, Edinburgh, UK
| | - Carole Hunter
- Alcohol and Drug Services, NHS Greater Glasgow and Clyde, G51 1DP, Glasgow, UK
| | - Saket Priyadarshi
- Alcohol and Drug Services, NHS Greater Glasgow and Clyde, G51 1DP, Glasgow, UK
| | - Tessa Parkes
- Faculty of Social Sciences, University of Stirling, FK9 4LA, Stirling, UK
| |
Collapse
|
5
|
Lalanne L, Roux P, Donadille C, Briand Madrid L, Célerier I, Chauvin C, Hamelin N, Kervran C, Maradan G, Auriacombe M, Jauffret-Roustide M. Drug consumption rooms are effective to reduce at-risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study. Addiction 2024; 119:180-199. [PMID: 37743675 DOI: 10.1111/add.16320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Accepted: 07/05/2023] [Indexed: 09/26/2023]
Abstract
AIMS The primary aim of this study was to evaluate the impact of drug consumption rooms (DCRs) in France on injection equipment-sharing, while the secondary aims focused upon their impact on access to hepatitis C virus (HCV) testing and opioid agonist treatment (OAT). DESIGN The COhort to identify Structural and INdividual factors associated with drug USe (COSINUS cohort) was a 12-month longitudinal study of 665 people who inject drugs (PWID), conducted in Bordeaux, Marseille, Paris and Strasbourg. We used data from face-to-face interviews at enrolment and at 6-month and 12-month visits. SETTING AND PARTICIPANTS The participants were recruited in harm reduction programmes in Bordeaux and Marseille and in DCRs in Strasbourg and Paris. Participants were aged more than 18 years, French-speaking and had injected substances the month before enrolment. MEASUREMENTS We measured the impact of DCR exposure on injection equipment sharing, HCV testing and the use of medications for opioid use disorder, after adjustment for significant correlates. We used a two-step Heckman mixed-effects probit model, which allowed us to take into account the correlation of repeated measures and to control for potential bias due to non-randomization between the two groups (DCR-exposed versus DCR-unexposed participants). FINDINGS The difference of declared injection equipment sharing between PWID exposed to DCRs versus non-exposed was 10% (1% for those exposed versus 11% for those non-exposed, marginal effect = -0.10; 95% confidence interval = -0.18, -0.03); there was no impact of DCRs on HCV testing and OAT. CONCLUSIONS In the French context, drug consumption rooms appear to have a positive impact on at-risk practices for infectious diseases such as human immunodeficiency virus (HIV) and hepatitis C virus.
Collapse
Affiliation(s)
- Laurence Lalanne
- INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France
- Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France
| | - Perrine Roux
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - Cécile Donadille
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - Laelia Briand Madrid
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - Isabelle Célerier
- ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - Carole Chauvin
- Centre d'étude des Mouvements Sociaux (Inserm U1276/CNRS UMR8044/EHESS), Paris, France
| | - Naomi Hamelin
- INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France
| | - Charlotte Kervran
- Addiction Team, SANPSY, CNRS UMR 6033, Bordeaux, France
- CH Charles Perrens and CHU de Bordeaux, Pôle inter-établissement Addictologie, Bordeaux, France
- Université Bordeaux, Bordeaux, France
| | - Gwenaëlle Maradan
- ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - Marc Auriacombe
- Addiction Team, SANPSY, CNRS UMR 6033, Bordeaux, France
- CH Charles Perrens and CHU de Bordeaux, Pôle inter-établissement Addictologie, Bordeaux, France
- Université Bordeaux, Bordeaux, France
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Marie Jauffret-Roustide
- Centre d'étude des Mouvements Sociaux (Inserm U1276/CNRS UMR8044/EHESS), Paris, France
- British Columbia Center on Substance Use (BCCSU), Vancouver, Canada
- Baldy Center on Law and Social Policy, Buffalo University, New York City, NY, USA
| |
Collapse
|
6
|
Whiteside B, Dunn M. Voices represented and voices silenced: Represented voices in the media coverage of the implementation of a supervised injecting facility. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2023; 121:104213. [PMID: 37776603 DOI: 10.1016/j.drugpo.2023.104213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Revised: 09/15/2023] [Accepted: 09/20/2023] [Indexed: 10/02/2023]
Abstract
BACKGROUND Victoria's first medically supervised injecting room (MSIR) has remained controversial despite mounting evidence in support of the facility. The opposition to a policy idea is subject to a myriad of factors including the media. Favouring the opinions of various actors, the media are a fundamental element of the narrative formation process. In this article, we examine the voices represented and voice silenced in print news media and the possible effects of such reporting. METHODS A quantitative content and qualitative thematic analysis of Victorian print media (n=645) focusing on the implementation and continued operation of North Richmond Community Health's medically supervised injecting room was conducted. RESULTS The representations of the MSIR were debated by three predominant actors - politicians, public, and residents. Politicians largely relied on the 'saving lives' rhetoric when supporting the facility. In addition, competing representations of 'public amenity' were presented by both advocates and proponents of the MSIR. We found the voices of people who inject drugs were inadequately represented within the data. Instead, overdose statistics were featured as were discursive descriptions of people who inject drugs such as 'addicts', 'junkies', and 'druggies'. CONCLUSION Despite people who inject drugs being the population the MSIR is designed to benefit, their experiences and voices were lacking, highlighting social power structures, denying the silenced power, and obstructing social change. Overdose rates were consistently presented as numbers, negating personal experiences and lacking meaningful debate. Further, negative discourse referring to people who inject drugs may have implications regarding internalised and externalised stigma and drug policy.
Collapse
Affiliation(s)
- Bianca Whiteside
- School of Health and Social Development, Faculty of Health, Deakin University, Burwood, Australia; Institute for Health Transformation, Faculty of Health, Deakin University, Australia.
| | - Matthew Dunn
- School of Health and Social Development, Faculty of Health, Deakin University, Burwood, Australia; Institute for Health Transformation, Faculty of Health, Deakin University, Australia
| |
Collapse
|
7
|
Chappuy M, Lack P, David B, Penavayre G, Thabourey D, Landulpho M, Plasse A, Icard C, Bailly F, Boutahra F, Pradat P, Maynard M, Jauffret-Roustide M, de Ternay J, Rolland B. Willingness to use a drug consumption room among people who use drugs in Lyon, France, a city with no open scene of drug use (the TRABOUL survey). Harm Reduct J 2023; 20:149. [PMID: 37845698 PMCID: PMC10580523 DOI: 10.1186/s12954-023-00887-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2023] [Accepted: 10/09/2023] [Indexed: 10/18/2023] Open
Abstract
BACKGROUND Drug consumption rooms (DCRs) have been developed in cities with open drug scenes, with the aim to reduce drug-related harm. In Lyon, France's second-largest city, there is no distinct drug use area, which raised doubts regarding the need for a DCR. METHODS We conducted a face-to-face survey of 264 people who use drugs (PWUDs), recruited in harm reduction or addiction treatment centers, in the streets or in squats. We assess their willingness to use a DCR, and we collected sociodemographic and medical features. Bivariable comparisons and analyses adjusted for sociodemographic parameters explored the association between willing to use a DCR and other variables, thus providing crude (ORs) and adjusted odds ratios (aORs) and 95% confidence intervals (95% CI). RESULTS In total, 193 (73.1%) PWUDs accepted to participate (mean age 38.5 ± 9.3 years; 80.3% men). Among them, 64.2% declared willing to use a DCR. Being treatment-seeker (aOR 0.20, 95% CI [0.08-0.51]; p < 0.001) and not living alone (aOR 0.29; 95% CI [0.10-0.86], p = 0.025) were negatively associated with willing to use a DCR. By contrast, receiving precarity social insurance (aOR 4.12; 95% CI [1.86-9.14], p < 0.001), being seropositive for hepatitis C (aOR 3.60; 95% CI [1.20-10.84], p = 0.022), being cannabis user (aOR 2.45; 95% CI [1.01-5.99], p = 0.049), and reporting previous problems with residents (aOR 5.99; 95% CI [2.16-16.58], p < 0.001) or with the police (aOR = 4.85; 95% CI [1.43-16.39], p = 0.011) were positively associated. CONCLUSIONS PWUDs, especially the most precarious ones, largely supported the opening of a DCR in Lyon, a city with no open drug scene.
Collapse
Affiliation(s)
- Mathieu Chappuy
- Service d'Hépatologie et d'Addictologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
- Service Universitaire d'Addictologie de Lyon (SUAL), Hospices Civils de Lyon, Hôpital Edouard Herriot, Pavillon K, 5 Place d'Arsonval, 69002, Lyon, France
- Service Universitaire d'Addictologie de Lyon (SUAL), CH Le Vinatier, Bron, France
- Service Pharmaceutique, Hospices Civils de Lyon, Lyon, France
| | - Philippe Lack
- Service d'Hépatologie et d'Addictologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
| | - Baptiste David
- Service d'Hépatologie et d'Addictologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
| | | | | | | | | | - Christophe Icard
- Service Universitaire d'Addictologie de Lyon (SUAL), CH Le Vinatier, Bron, France
| | - François Bailly
- Service d'Hépatologie et d'Addictologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
| | | | - Pierre Pradat
- Centre de Recherche Clinique, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France
| | - Marianne Maynard
- Centre de Recherche Clinique, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France
| | - Marie Jauffret-Roustide
- Centre d'Étude Des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France
- British Columbia Center on Substance Use (BCCSU), British Columbia University, Vancouver, Canada
- Baldy Center on Law and Social Policy, Buffalo University, Buffalo, USA
| | - Julia de Ternay
- Service Universitaire d'Addictologie de Lyon (SUAL), Hospices Civils de Lyon, Hôpital Edouard Herriot, Pavillon K, 5 Place d'Arsonval, 69002, Lyon, France
- Univ. Lyon, UCBL1, INSERM U1028, CNRS UMR5292, CRNL, PSYR2, Lyon, France
| | - Benjamin Rolland
- Service Universitaire d'Addictologie de Lyon (SUAL), Hospices Civils de Lyon, Hôpital Edouard Herriot, Pavillon K, 5 Place d'Arsonval, 69002, Lyon, France.
- Service Universitaire d'Addictologie de Lyon (SUAL), CH Le Vinatier, Bron, France.
- Univ. Lyon, UCBL1, INSERM U1028, CNRS UMR5292, CRNL, PSYR2, Lyon, France.
| |
Collapse
|
8
|
Demina A, Desprès C, Mamzer MF. A qualitative study of professionals' perspectives on the ethics of medically-delivered safer injection education for people who inject drugs. BMC Med Ethics 2023; 24:63. [PMID: 37568123 PMCID: PMC10422818 DOI: 10.1186/s12910-023-00939-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Accepted: 07/26/2023] [Indexed: 08/13/2023] Open
Abstract
BACKGROUND In this qualitative analysis we aimed to explore addiction physicians' perspectives on safer injection education for people who inject drugs, especially: (1) on possible means of introducing safer injection education in the medical environment, (2) on the compatibility of safer injection education with each physician's core values and goals, and (3) on possible reasons for the ethical dilemma in safer injection education. METHODS We conducted semi-structured interviews with eleven physicians practicing addiction medicine in France in clinical and harm reduction settings. RESULTS All participants were in favor of educational interventions for people who inject drugs. Nonetheless, these interventions varied from simple advice to injection supervision and they were seen as less acceptable when they concerned the practical and material aspects of injection. Some participants found that physicians practicing in clinical settings, where patients consult mostly to stop their drug use, should not practice safer injection education. On the contrary, other participants claimed that safer injection education was essential in all settings and was not a choice but rather a duty for addiction physicians. The ethical dilemma of such intervention when delivered by medical staff was viewed as a complex phenomenon, related to the representations of intravenous drug use and to societal expectations from physicians. CONCLUSION Physicians' views on safer injection education for people who inject drugs reveal an emotionally charged subject related to the structural organization of addiction management in France. Such education is marked by an arduous history of harm reduction policies in France. IRB REGISTRATION: #00011928.
Collapse
Affiliation(s)
- Anastasia Demina
- Addiction medicine department, CHU Dijon Bourgogne, Dijon, France.
- Université de Bourgogne, INSERM U1093 « Cognition, Action et Plasticité Sensorimotrice », Dijon, France.
- Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Laboratoire ETREs, Inserm, Paris, F-75006, France.
| | - Caroline Desprès
- Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Laboratoire ETREs, Inserm, Paris, F-75006, France
| | - Marie-France Mamzer
- Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Laboratoire ETREs, Inserm, Paris, F-75006, France
- Unité Fonctionnelle d'Ethique Médicale, Hôpital Necker-Enfants malades, APHP, 149 rue de Sèvres, Paris, 75015, France
| |
Collapse
|
9
|
Dos Santos M, Girard G, Briand Madrid L, Perreaut L, Olenine A, Roux P. "The Slums Have To Be Shown": Documenting Drug Injection in Public Spaces Ahead of the Opening of a Drug Consumption Room in Marseille. QUALITATIVE HEALTH RESEARCH 2023:10497323231169607. [PMID: 37271754 DOI: 10.1177/10497323231169607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
EPOSIM is a community-based participatory research study which used the Photovoice method with people who inject drugs (PWID) ahead of a possible opening of a drug consumption room (DCR) in Marseille, France. It aimed to identify the strategies used by PWID when injecting, and the risks they take when they have no safe private space to inject in the area they live in. A total of 7 PWID participated in the full study process. The 189 photographs they took provided us with a good understanding of their injection practices in public places. The main results highlighted the spatiality and materiality of injecting experience in a context where no DCR was available. They also showed the relevance of Photovoice to valorize the voices of PWID when implementing a DCR. Through the showcasing of their photographs at various public exhibitions, the participants seized the opportunity to use Photovoice to make their voices heard beyond the group formed for the study, in order to show the different forms of stigma and insalubrious contexts which they faced on a daily basis. Furthermore, the photographs taken demonstrated that having only health and safety records is not enough to fully understand PWID injection practices. Future studies must take into account PWID perceptions of their relationship with injecting in public spaces and with the management of stigma. The questions of pleasure and comfort must also be explored in evaluation studies of harm reduction measures, for example, DCR.
Collapse
Affiliation(s)
- Marie Dos Santos
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, Faculté de médecine, Marseille, France
| | - Gabriel Girard
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, Faculté de médecine, Marseille, France
| | - Laélia Briand Madrid
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, Faculté de médecine, Marseille, France
| | - Lola Perreaut
- Asud Mars Say Yeah Harm Reduction, Marseille, France
| | | | - Perrine Roux
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, Faculté de médecine, Marseille, France
| |
Collapse
|
10
|
Briand Madrid L, Donadille C, Célerier I, Gutowski M, Grelli N, Maradan G, Jauffret-Roustide M, Lalanne L, Auriacombe M, Roux P. [Drug Consumption Rooms : Opinion and willingness among people who inject drugs in Marseille, France]. Rev Epidemiol Sante Publique 2023; 71:101421. [PMID: 36571957 DOI: 10.1016/j.respe.2022.101421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2022] [Revised: 12/01/2022] [Accepted: 12/05/2022] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND In France, people who inject drugs (PWID) are still one of the most at risk population for contracting hepatitis C virus (HCV). Drug consumption rooms (DCR) have shown their effectiveness on HCV risk behaviors abroad and in France, where they have been recently evaluated with the COSINUS study. In France, two DCRs opened in 2016, one in Paris and another in Strasbourg. The objective of this sub-analysis was to explore the willingness to use a DCR in PWID living in Marseille, where no DCR is opened. METHODS The COSINUS study is a prospective multicenter cohort that included 665 PWID recruited in Bordeaux, Marseille, Paris and Strasbourg between 2016 and 2019. Investigators administered questionnaires face-to-face at regular intervals at baseline, 3 months, 6 months and 12 months. In Marseille, 199 PWID were recruited. A multivariable logistic regression model was performed to assess factors associated with willingness to use DCR among this population. RESULTS Among 545 observations corresponding to 195 distinct participants selected for analyses, 57% declared they were willing to attend a DCR. The main reason given was "to consume more cleanly". Receiving allowances (OR = 2.38; 95% confidence interval (CI) (95% CI) = 1.17-4.81), not having health insurance (OR = 3.61; 95% CI = 1.49-8.75), injecting daily (OR = 1.97; 95% CI = 1.05-3.70) and in a public space (OR = 2.66; 95% CI = 1.29-5.47) were all positively associated with willingness to use a DCR. CONCLUSIONS DCR are devices that target PWID exposed to high sanitary or social risks, i.e. people living in precarious conditions, who have to inject in public spaces, in deleterious sanitary environments and with rapid gestures in order not to be seen. These analyzes highlight that the people who most want to attend a DCR are aware of the harms associated with their practices and show a desire to seek protection from street-based drug scenes.
Collapse
Affiliation(s)
- L Briand Madrid
- Aix Marseille Université, Inserm, IRD, SESSTIM, Sciences économiques & sociales de la santé & traitement de l'information médicale, ISSPAM, Marseille, France.
| | - C Donadille
- Aix Marseille Université, Inserm, IRD, SESSTIM, Sciences économiques & sociales de la santé & traitement de l'information médicale, ISSPAM, Marseille, France
| | | | | | - N Grelli
- Nouvelle Aube, Marseille, France
| | - G Maradan
- ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - M Jauffret-Roustide
- British Columbia Center on Substance Use (BCCSU), Vancouver, Canada; Baldy Center on Law and Social Policy, Buffalo University, New York, USA; Centre d'étude des mouvements sociaux, Inserm U1276/CNRS UMR 8044/EHESS, Paris, France
| | - L Lalanne
- Inserm 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de médecine translationnelle de Strasbourg (FMTS), 67000 Strasbourg, France; Department of Addictology, University Hospital of Strasbourg, Fédération de médecine translationnelle de Strasbourg (FMTS), 67000 Strasbourg, France
| | - M Auriacombe
- Bordeaux University, SANPSY, CNRS UMR 6033, Bordeaux, France; Addiction Clinic (Pôle interétablissement d'addictologie), CHU Bordeaux and CH Charles Perrens, Bordeaux, France
| | - P Roux
- Aix Marseille Université, Inserm, IRD, SESSTIM, Sciences économiques & sociales de la santé & traitement de l'information médicale, ISSPAM, Marseille, France
| | | |
Collapse
|
11
|
Taylor H, Leite Â, Gautier D, Nunes P, Pires J, Curado A. Community perceptions surrounding Lisbon's first mobile drug consumption room. DIALOGUES IN HEALTH 2022; 1:100031. [PMID: 38515893 PMCID: PMC10954018 DOI: 10.1016/j.dialog.2022.100031] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 02/13/2022] [Revised: 07/19/2022] [Accepted: 07/19/2022] [Indexed: 03/23/2024]
Abstract
Portugal's first Mobile Drug Consumption Room (MDCR) has been operating for over three years in two Lisbon neighborhoods. This qualitative study first creates a baseline understanding of community perceptions concerning the acceptability of and expectations surrounding drug consumption rooms in the communities of intervention. Then, at least six months after the initial interviews, it determines how these perceptions changed and what changes participants perceive in the neighborhoods. Findings highlight widespread acceptance of the MDCR among participants. One of the participants' priorities related to the MDCR was to lessen the visibility of public consumption, a change some participants perceived in the neighborhood. While in the first round of data collection participants primarily conceptualized the MDCR as a service for People Who Use Drugs (PWUD), in the follow-up round, they reported changes in the community.
Collapse
Affiliation(s)
| | - Ângela Leite
- Grupo de Ativistas em Tratamentos – GAT, Portugal
| | | | | | | | | |
Collapse
|
12
|
Roux P, Jauffret-Roustide M, Donadille C, Briand Madrid L, Denis C, Célérier I, Chauvin C, Hamelin N, Maradan G, Carrieri MP, Protopopescu C, Lalanne L, Auriacombe M. Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort. Int J Epidemiol 2022; 52:562-576. [PMID: 35690956 DOI: 10.1093/ije/dyac120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Accepted: 05/17/2022] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND The effectiveness of drug consumption rooms (DCRs) for people who inject drugs (PWID) has been demonstrated for HIV and hepatitis C virus risk practices, and access to care for substance use disorders. However, data on other health-related complications are scarce. Using data from the French COSINUS cohort, we investigated the impact of DCR exposure on non-fatal overdoses, abscesses and emergency department (ED) visits, all in the previous 6 months. METHODS COSINUS is a 12-month prospective cohort study of 665 PWID in France studying DCR effectiveness on health. We collected data from face-to-face interviews at enrolment, and at 6 and 12 months of follow-up. After adjusting for other correlates (P-value < 0.05), the impact of DCR exposure on each outcome was assessed using a two-step Heckman mixed-effects probit model, allowing us to adjust for potential non-randomization bias due to differences between DCR-exposed and DCR-unexposed participants, while taking into account the correlation between repeated measures. RESULTS At enrolment, 21%, 6% and 38% of the 665 participants reported overdoses, abscesses and ED visits, respectively. Multivariable models found that DCR-exposed participants were less likely to report overdoses [adjusted coefficient (95% CI): -0.47 (-0.88; -0.07), P = 0.023], abscesses [-0.74 (-1.11; -0.37), P < 0.001] and ED visits [-0.74 (-1.27; -0.20), P = 0.007]. CONCLUSION This is the first study to show the positive impact of DCR exposure on abscesses and ED visits, and confirms DCR effectiveness in reducing overdoses, when adjusting for potential non-randomization bias. Our findings strengthen the argument to expand DCR implementation to improve PWID injection environment and health.
Collapse
Affiliation(s)
- P Roux
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - M Jauffret-Roustide
- Cermes3, Inserm U988/CNRS UMR 8211/EHESS/Université de Paris, Paris, France
- British Columbia Center on Substance Use, Vancouver, Canada
- Baldy Center on Law and Social Policy, Buffalo University, Buffalo, NY, USA
| | - C Donadille
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - L Briand Madrid
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - C Denis
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- Univ. Bordeaux, Bordeaux, France
- Sleep, Addiction and Neuropsychiatry research laboratory (SANPSY), CNRS UMR 6033, Bordeaux, France
- Pôle Addictologie, CH Charles Perrens and CHU de Bordeaux, Bordeaux, France
| | - I Célérier
- ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - C Chauvin
- Cermes3, Inserm U988/CNRS UMR 8211/EHESS/Université de Paris, Paris, France
| | - N Hamelin
- INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France
| | - G Maradan
- ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - M P Carrieri
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - C Protopopescu
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France
| | - L Lalanne
- INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France
- Department of Psychiatry and Addictology, University Hospital of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France
| | - M Auriacombe
- Univ. Bordeaux, Bordeaux, France
- Sleep, Addiction and Neuropsychiatry research laboratory (SANPSY), CNRS UMR 6033, Bordeaux, France
- Pôle Addictologie, CH Charles Perrens and CHU de Bordeaux, Bordeaux, France
| |
Collapse
|
13
|
Unlu A, Tammi T, Hakkarainen P. Stakeholders’ Problematisation of Drug Consumption Rooms: A Case Study of the Policy Initiative in Helsinki. JOURNAL OF DRUG ISSUES 2022. [DOI: 10.1177/00220426221093609] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Drug consumption rooms are one of the harm reduction interventions to handle complex social problems. The Helsinki city initiative puts drug consumption room (DCR) on a government agenda in Finland, which has also triggered a broader discussion. This study presents how stakeholders problematise and what solutions they propose for DCRs. The research is based on in-depth interviews of 23 stakeholders and the theoretical perspective of Bacchi’s approach – ‘What’s the problem represented to be?’ (WPR). The results show that while stakeholders’ solutions resemble each other on the core DCR functions, the variations are found mainly in the introduction of extended services, policy development strategy, types of drug allowance in DCRs, and drug testing options. Stigmatisation of PWUDs still leads the harm reduction services to be considered from a moral framework. Stakeholders tend to take their positions according to strategic considerations related to electoral politics, expedience and the symbolic role of policies.
Collapse
Affiliation(s)
- Ali Unlu
- Finnish Institute for Health and Welfare (THL), Alcohol, Drugs and Tobacco Unit, Helsinki, Finland
| | - Tuukka Tammi
- Research Program Director, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
| | - Pekka Hakkarainen
- Research Professor, Alcohol, Drugs and Tobacco Unit, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
| |
Collapse
|
14
|
Goulian A, Jauffret-Roustide M, Dambélé S, Singh R, Fullilove RE. A cultural and political difference: comparing the racial and social framing of population crack cocaine use between the United States and France. Harm Reduct J 2022; 19:44. [PMID: 35550157 PMCID: PMC9096779 DOI: 10.1186/s12954-022-00625-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2021] [Accepted: 04/19/2022] [Indexed: 11/10/2022] Open
Affiliation(s)
- Andrew Goulian
- Columbia University, Mailman School of Public Health, New York, USA.
| | - Marie Jauffret-Roustide
- CEMS, Inserm U1276, CNRS UMR 8044, EHESS, Paris, France.,British Columbia Centre on Substance Use (BCCSU), Vancouver, Canada.,Baldy Center for Law and Social Policy, Buffalo University of Social Sciences, New York, USA.,Institut Convergences Migrations, Campus Condorcet, Aubervilliers, France
| | - Sayon Dambélé
- Agence Nationale de L'Inclusion Économique et Sociale, Conakry, Guinea
| | - Rajvir Singh
- Columbia University, Mailman School of Public Health, New York, USA.,Rural Workforce Agency Victoria, Melbourne, Australia
| | | |
Collapse
|
15
|
Davidson PJ, Wenger LD, Lambdin BH, Kral AH. Establishment and Enforcement of Operational Rules at an Unsanctioned Safe Drug Consumption Site in the United States, 2014-2020. Am J Public Health 2022; 112:S166-S172. [PMID: 35349308 PMCID: PMC8965194 DOI: 10.2105/ajph.2022.306714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/02/2022] [Indexed: 11/04/2022]
Abstract
Objectives. To examine how operational rules are established and enforced at an unsanctioned safe consumption site (SCS) operating in the United States. Methods. We conducted 44 qualitative interviews with people who use drugs, staff members, and volunteers at an unsanctioned SCS and analyzed them using an inductive thematic approach. Results. Rule-making processes were largely driven by concerns raised by service users rather than driven by external pressures, and iterated rapidly in response to changing needs. The unsanctioned nature of the site produced an environment where bottom-up rule-making was critical to generating a shared sense of ownership of the site and where enforcement was necessarily fluid. Conclusions. Removing external restrictions on operational rules for SCSs results in a flexible set of rules that are highly responsive to the social and public health needs of people who use drugs. Legislation and regulations of SCSs should aim to place as few hard limits on operating conditions as possible to maximize involvement of and responsiveness to people who use drugs. (Am J Public Health. 2022;112(S2):S166-S172. https://doi.org/10.2105/AJPH.2022.306714).
Collapse
Affiliation(s)
- Peter J Davidson
- Peter J. Davidson is with the Division of Infectious Disease & Global Public Health, Department of Medicine, University of California, San Diego. Lynn D. Wendger, Barrot H. Lambdin, and Alex H. Kral are with the Community Health Research Division, RTI International, Berkeley CA
| | - Lynn D Wenger
- Peter J. Davidson is with the Division of Infectious Disease & Global Public Health, Department of Medicine, University of California, San Diego. Lynn D. Wendger, Barrot H. Lambdin, and Alex H. Kral are with the Community Health Research Division, RTI International, Berkeley CA
| | - Barrot H Lambdin
- Peter J. Davidson is with the Division of Infectious Disease & Global Public Health, Department of Medicine, University of California, San Diego. Lynn D. Wendger, Barrot H. Lambdin, and Alex H. Kral are with the Community Health Research Division, RTI International, Berkeley CA
| | - Alex H Kral
- Peter J. Davidson is with the Division of Infectious Disease & Global Public Health, Department of Medicine, University of California, San Diego. Lynn D. Wendger, Barrot H. Lambdin, and Alex H. Kral are with the Community Health Research Division, RTI International, Berkeley CA
| |
Collapse
|
16
|
Jauffret-Roustide M, Houborg E, Southwell M, Chronopoulou D, Granier JM, Frank VA, Stevens A, Rhodes T. Different Paths and Potentials to Harm Reduction in Different Welfare States: Drug Consumption Rooms in the United Kingdom, Denmark, and France. Am J Public Health 2022; 112:S99-S103. [PMID: 35349322 PMCID: PMC8965185 DOI: 10.2105/ajph.2022.306790] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/12/2022] [Indexed: 11/04/2022]
Affiliation(s)
- Marie Jauffret-Roustide
- Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Esben Houborg
- Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Matthew Southwell
- Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Daphné Chronopoulou
- Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Jean-Maxence Granier
- Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Vibeke Asmussen Frank
- Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Alex Stevens
- Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Tim Rhodes
- Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| |
Collapse
|
17
|
Nguemeni Tiako MJ, Netherland J, Hansen H, Jauffret-Roustide M. Drug Overdose Epidemic Colliding With COVID-19: What the United States Can Learn From France. Am J Public Health 2022; 112:S128-S132. [PMID: 35349315 PMCID: PMC8965177 DOI: 10.2105/ajph.2022.306763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/23/2022] [Indexed: 11/04/2022]
Affiliation(s)
- Max Jordan Nguemeni Tiako
- Max Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue
| | - Jules Netherland
- Max Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue
| | - Helena Hansen
- Max Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue
| | - Marie Jauffret-Roustide
- Max Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue
| |
Collapse
|
18
|
Nguyen TT, Tran MTN, Le GM, Jauffret-Roustide M. Drug Harm Reduction in Vietnam: A Review of Stakeholders' Perspectives and Implications for Future Interventions. Am J Public Health 2022; 112:S182-S190. [PMID: 35349313 PMCID: PMC8965182 DOI: 10.2105/ajph.2022.306764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/23/2022] [Indexed: 11/04/2022]
Abstract
Objectives. To determine how harm reduction should be applied in low-resource countries such as Vietnam by exploring the perspectives of people who use drugs (PWUD), health care professionals, and policymakers regarding methadone treatment and harm reduction strategies. Methods. We conducted 2 qualitative studies in Vietnam between 2016 and 2021. We interviewed 62 PWUD and 22 experts in drug policy development and drug treatment programs, conducted observations at methadone clinics and harm reduction program meetings, and analyzed drug policy documents. Results. PWUD considered methadone treatment only as a transition to a drug-free life. Policymakers deemed harm reduction ineffective and continued to enforce arrest and incarceration of PWUD. Drug intervention programs are not yet geared to providing specialized services. Effective communication strategies and information on evidence-based harm reduction models are inadequate to help policymakers make the right decisions. Conclusions. Harm reduction principles have not been fully adopted in Vietnam. A harm reduction strategy based on a more humanistic approach that goes beyond a biomedicalized approach is urgently needed in Vietnam and other countries in the Global South. (Am J Public Health. 2022;112(S2):S182-S190. https://doi.org/10.2105/AJPH.2022.306764).
Collapse
Affiliation(s)
- Trang Thu Nguyen
- Trang Thu Nguyen, Mai Thi Ngoc Tran, and Giang Minh Le are with the Center for Training and Research on Substance Abuse and HIV, Hanoi Medical University, Hanoi, Vietnam. Tran Thi Ngoc Mai is also with the School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia. Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (CNRS UMR8044/Inserm U1276/EHESS), Paris, France and the British Columbia Center on Substance Use, Vancouver, BC, Canada. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Mai Thi Ngoc Tran
- Trang Thu Nguyen, Mai Thi Ngoc Tran, and Giang Minh Le are with the Center for Training and Research on Substance Abuse and HIV, Hanoi Medical University, Hanoi, Vietnam. Tran Thi Ngoc Mai is also with the School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia. Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (CNRS UMR8044/Inserm U1276/EHESS), Paris, France and the British Columbia Center on Substance Use, Vancouver, BC, Canada. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Giang Minh Le
- Trang Thu Nguyen, Mai Thi Ngoc Tran, and Giang Minh Le are with the Center for Training and Research on Substance Abuse and HIV, Hanoi Medical University, Hanoi, Vietnam. Tran Thi Ngoc Mai is also with the School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia. Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (CNRS UMR8044/Inserm U1276/EHESS), Paris, France and the British Columbia Center on Substance Use, Vancouver, BC, Canada. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Marie Jauffret-Roustide
- Trang Thu Nguyen, Mai Thi Ngoc Tran, and Giang Minh Le are with the Center for Training and Research on Substance Abuse and HIV, Hanoi Medical University, Hanoi, Vietnam. Tran Thi Ngoc Mai is also with the School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia. Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (CNRS UMR8044/Inserm U1276/EHESS), Paris, France and the British Columbia Center on Substance Use, Vancouver, BC, Canada. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| |
Collapse
|
19
|
Houborg E, Jauffret-Roustide M. Drug Consumption Rooms: Welfare State and Diversity in Social Acceptance in Denmark and in France. Am J Public Health 2022; 112:S159-S165. [PMID: 35349316 PMCID: PMC8965187 DOI: 10.2105/ajph.2022.306808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/12/2022] [Indexed: 11/04/2022]
Abstract
Drug consumption rooms (DCRs) have the potential to have a positive impact on the opioid overdose crisis. DCRs could also potentially change the political environment for public health because they can affect the distribution of responsibility for harm reduction between the individual and society by collectivizing responsibility for harm reduction through welfare regimes. The methodology is based on 2 case studies-1 in Copenhagen, Denmark, and 1 in Paris, France-about residents, people who inject drugs (PWID), and politicians' experiences of DCRs involving semidirective interviews. Denmark has a long history of harm-reduction policy, and the implementation of DCRs in Copenhagen has happened through close collaboration between local authorities and the local community. France is far more centralized and paternalistic in terms of the distribution of authority and decision-making in welfare and drug policy. Difficulties in cohabitation between local residents and PWID happened in both countries and can sometimes make public authorities hesitate to implement DCRs because of the NIMBY ("not in my backyard") phenomenon. However, the Danish and French case studies show that DCRs have the potential to become an instrument for civic cohabitation as well as to contribute to the destigmatization and health of PWID. (Am J Public Health. 2022;112(S2):S159-S165. https://doi.org/10.2105/AJPH.2022.306808).
Collapse
Affiliation(s)
- Esben Houborg
- Esben Houborg is with the Center for Drug and Alcohol Research, Aarhus University, Copenhagen, Denmark. Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France; the Baldy Center for Law and Social Policy, Buffalo University, Buffalo, NY; and the British Columbia Center on Substance Use, Vancouver, BC, Canada. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| | - Marie Jauffret-Roustide
- Esben Houborg is with the Center for Drug and Alcohol Research, Aarhus University, Copenhagen, Denmark. Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France; the Baldy Center for Law and Social Policy, Buffalo University, Buffalo, NY; and the British Columbia Center on Substance Use, Vancouver, BC, Canada. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue
| |
Collapse
|
20
|
Whiteside B, Dunn M. The print media's construction of the 'drug problem' in Victorian newspapers: The case of North Richmond Community Health's medically supervised injecting room. Drug Alcohol Rev 2021; 41:818-829. [PMID: 34674323 DOI: 10.1111/dar.13392] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2021] [Revised: 09/01/2021] [Accepted: 09/02/2021] [Indexed: 01/08/2023]
Abstract
INTRODUCTION The media's influence on policy has been widely documented. This study sought to investigate how Melbourne's medically supervised injecting room (MSIR) was represented in the print media. METHODS A qualitative discourse analysis of Victorian print media (n = 441 items) representation of MSIR was conducted. Constructivist Grounded Theory guided the sampling strategy and coding while the discourse analysis was informed by Bacchi's approach to policy analysis, 'What's the problem represented to be?'. Print news media was gathered from Factiva and Newsbank databases from January 2016 to June 2020. RESULTS The media's representation of the 'drug problem' of overdose was identified by a range of actors in support and opposition of the facility. In attributing the concept of 'drug use' to the 'drug problem' items most frequently suggest it is the 'choice' of the individual to inject illicit drugs. The voices of people who inject drugs (PWID) were largely silenced in the print news media and to re-conceptualise the 'drug problem' to be a 'health problem' would aid in the support for the harm reduction strategy. The research highlighted 'dividing practices' (residents vs. PWID) and the portrayal of PWID that translate to the lived effects of PWID. DISCUSSION AND CONCLUSIONS The print news media did not directly influence the establishment of the Melbourne MSIR. However, the representation of PWID in the print media must be further investigated for the successful establishment of future harm reduction strategies.
Collapse
Affiliation(s)
- Bianca Whiteside
- School of Health and Social Development, Faculty of Health, Deakin University, Geelong, Australia
| | - Matthew Dunn
- School of Health and Social Development, Faculty of Health, Deakin University, Geelong, Australia
| |
Collapse
|
21
|
Germes M, Werse B, Jauffret-Roustide M. Guest editorial. DRUGS AND ALCOHOL TODAY 2021. [DOI: 10.1108/dat-09-2021-086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
22
|
Jangal C, Lovera M, Dambélé S, Jauffret-Roustide M. Sociological and spatial dynamics of an evolving Parisian open drug scene: the case of the “Colline du Crack”. DRUGS AND ALCOHOL TODAY 2021. [DOI: 10.1108/dat-02-2021-0010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Purpose
In November 2019, an open drug scene, commonly called “Colline du crack” and located in Paris was forcibly closed after 10 years of existence. This paper aims to understand how that space has evolved over the years to become a major hub for drug use.
Design/methodology/approach
The authors used a qualitative approach that included interviews with 52 people who use drugs (PWUD) and 54 field professionals and ethnographic observations. The authors asked questions about the evolution of the major sites of crack visibility in Paris and about social representations related to these spaces. They compared their datas with datas drawn from gray literature.
Findings
La Colline emerged on an isolated slope, away from police repression and local anti-crack organizations. In the beginning, it was a discrete, communal space regulated by PWUD. Starting in 2015, social transformations in the neighborhood turned la Colline into a central hub for dealing and using crack. La Colline became an open scene which led to its evacuation in 2019.
Originality/value
This paper contributes to literature on community building of drug consumers. The authors are also using a wide variety of methodological tools.
Collapse
|
23
|
Rudzinski K, Xavier J, Guta A, Chan Carusone S, King K, Phillips JC, Switzer S, O'Leary B, Baltzer Turje R, Harrison S, de Prinse K, Simons J, Strike C. Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a specialty HIV hospital in Toronto, Canada: perspectives of people living with HIV. BMC Public Health 2021; 21:1482. [PMID: 34325681 PMCID: PMC8323264 DOI: 10.1186/s12889-021-11507-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2020] [Accepted: 07/19/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Substance use significantly impacts health and healthcare of people living with HIV/AIDS (PLHIV), especially their ability to remain in hospital following admission. Supervised injection services (SIS) reduce overdoses and drug-related harms, but are not often provided within hospitals/outpatient programs. Leading us to question, what are PLHIV's perceptions of hospital-based SIS? METHODS This mixed-methods study explored feasibility and acceptability of implementing SIS at Casey House, a Toronto-based specialty HIV hospital, from the perspective of its in/outpatient clients. We conducted a survey, examining clients' (n = 92) demand for, and acceptability of, hospital-based SIS. Following this, we hosted two focus groups (n = 14) and one-on-one interviews (n = 8) with clients which explored benefits/drawbacks of in-hospital SIS, wherein participants experienced guided tours of a demonstration SIS space and/or presentations of evidence about impacts of SIS. Data were analysed using descriptive statistics and thematic analysis. RESULTS Among survey participants, 76.1% (n = 70) identified as cis-male and over half (n = 49;54.4%) had been a hospital client for 2 years or less. Nearly half (48.8%) knew about clients injecting in/near Casey House, while 23.6% witnessed it. Survey participants were more supportive of SIS for inpatients (76.1%) than for outpatients (68.5%); most (74.7%) reported SIS implementation would not impact their level of service use at Casey House, while some predicted coming more often (16.1%) and others less often (9.2%). Most focus group/interview participants, believed SIS would enhance safety by reducing health harms (e.g. overdose), increasing transparency between clients and clinicians about substance use, and helping retain clients in care. Debate arose about who (e.g., in/outpatients vs. non-clients) should have access to hospital-based SIS and how implementation may shift organizational priorities/resources away from services not specific to drug use. CONCLUSIONS Our data showed widespread support of, and need for, hospital-based SIS among client stakeholders; however, attempts to reduce negative impacts on non-drug using clients need to be considered in the balance of implementation plans. Given the increased risks of morbidity and mortality for PLHIV who inject drugs as well as the problems in retaining them in care in a hospital setting, SIS is a key component of improving care for this marginalized group.
Collapse
Affiliation(s)
- Katherine Rudzinski
- Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, ON, M5T 3M7, Canada.
| | - Jessica Xavier
- Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, ON, M5T 3M7, Canada
| | - Adrian Guta
- School of Social Work, University of Windsor, 167 Ferry Street, Windsor, ON, N9A 0C5, Canada
| | - Soo Chan Carusone
- Casey House, 119 Isabella St, Toronto, ON, M4Y 1P2, Canada
- Department of Health Research Methodology, Evidence, and Impact, McMaster University, 1280 Main Street West 2C Area, Hamilton, ON, L8S 4K, Canada
| | - Kenneth King
- Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, ON, M5T 3M7, Canada
| | - J Craig Phillips
- Faculty of Health Sciences, University of Ottawa, 190 Laurier Avenue East, Ottawa, ON, K1N 6N5, Canada
| | - Sarah Switzer
- Ontario Institute for Studies in Education, University of Toronto, 252 Bloor Street West, Toronto, ON, M5S 1V6, Canada
| | - Bill O'Leary
- Casey House, 119 Isabella St, Toronto, ON, M4Y 1P2, Canada
- Factor-Inwentash Faculty of Social Work, University of Toronto, 246 Bloor Street W, Toronto, ON, M5S 1V4, Canada
| | | | - Scott Harrison
- Providence Health Care - St. Paul's Hospital, 1081 Burrard St, Vancouver, BC, V6Z 1Y6, Canada
| | | | - Joanne Simons
- Casey House, 119 Isabella St, Toronto, ON, M4Y 1P2, Canada
| | - Carol Strike
- Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, ON, M5T 3M7, Canada
- Li Ka Shing Knowledge Institute, St. Michael's Hospital, 209 Victoria St, Toronto, ON, M5B 1T8, Canada
| |
Collapse
|
24
|
Dányi E, Csák R. Drug places and spaces of problematisation: the melancholy case of a Hungarian needle exchange programme. DRUGS AND ALCOHOL TODAY 2021. [DOI: 10.1108/dat-12-2020-0084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Purpose
This paper aims to explore multiple problematisation processes through a former needle exchange programme run by Kék Pont (a non-governmental organisation) in the 8th district of Budapest. By presenting a collage of ethnographic stories, this paper attempts to preserve tacit knowledge associated with the programme and thereby keep its office alive as a “drug place”, the operation of which was made impossible in 2014.
Design/methodology/approach
Drawing on the insights of Foucauldian governmentality studies and actor-network theory, this paper focusses on drug use as a problem in its spatial-material settings. Based on ethnographic fieldwork, the contribution traces multiple problematisation processes and related infrastructures.
Findings
From the needle exchange programme’s perspective, drug use is not a singular problem but the effect of multiple problematisation processes. Although those processes are often in conflict with each other, the question is not which one is right, but how social workers manage to hold them together. It is a fragile achievement that requires years of training and ongoing negotiation with local actors. By eliminating Kék Pont’s 8th district office, the Hungarian Government did not only hinder harm reduction in the area but it had also rendered tacit knowledge associated with the needle exchange programme as a “drug place” inaccessible.
Originality/value
The paper is a melancholy intervention – an attempt to preserve tacit knowledge that had accumulated at the needle exchange programme. The retelling of ethnographic stories about this “drug place” is one way of ensuring that other drug policies remain imaginable.
Collapse
|
25
|
Munoz Sastre MT, Kpanake L, Mullet E. French People's positions on supervised injection facilities for drug users. Subst Abuse Treat Prev Policy 2020; 15:79. [PMID: 33054832 PMCID: PMC7557075 DOI: 10.1186/s13011-020-00321-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/07/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Supervised injection facilities have been set-up in many countries to curb the health risks associated with unsafe injection practices. These facilities have, however, been met with vocal opposition, notably in France. As harm reduction policies can only succeed to the extent that people agree with them, this study mapped French people's opinions regarding the setting-up of these facilities. METHOD A sample of 318 adults--among them health professionals--were presented with 48 vignettes depicting plans to create a supervised injection facility in their town. Each vignette contained three pieces of information: (a) the type of substance that would be injected in the facility (amphetamines only, amphetamines and cocaine only, or amphetamines, cocaine and heroin), (b) the type of staff who would be working in the facility (physicians and nurses, specially trained former drug users, specially trained current drug users, or trained volunteers recruited by the municipality), and (c) the staff members' mission (to be present and observe only, technical counselling about safe injection, counselling about safe injection and hygiene, or counselling and encouragement to follow a detoxification program). RESULTS Through cluster analysis, three qualitatively different positions were found: Not very acceptable (20%), Depends on staff and mission (49%), and Always acceptable (31%). These positions were associated with demographic characteristics--namely gender, age and political orientation. CONCLUSION French people's positions regarding supervised injection facilities were extremely diverse. One type of facility would, however, be accepted by a large majority of people: supervised injection facilities run by health professionals whose mission would be, in addition to technical and hygienic counselling, to encourage patrons to enter detoxification or rehabilitation programs.
Collapse
Affiliation(s)
- Maria Teresa Munoz Sastre
- CERPPS, Maison de la recherche, Federal University of Toulouse, 5 allées Antonio Machado, 31058 Toulouse cedex 9, France
| | - Lonzozou Kpanake
- University of Québec – TELUQ, 5800, rue Saint-Denis, Bureau 1105, Montréal (Québec), Montréal, H2S 3L5 Canada
| | - Etienne Mullet
- Institute of Advanced Studies (EPHE), 17 bis, rue Quefes, Plaisance du Touch, 31830 Paris, France
| |
Collapse
|
26
|
Sumnall HR, Atkinson AM, Trayner KMA, Gage SH, McAuley A. Effects of messaging on public support for drug consumption rooms in scotland, UK. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2020; 83:102855. [PMID: 32693322 DOI: 10.1016/j.drugpo.2020.102855] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Revised: 07/03/2020] [Accepted: 07/07/2020] [Indexed: 11/15/2022]
Abstract
BACKGROUND There is evidence to suggest that medically supervised drug consumption rooms (DCRs) may form part of responses to reduce drug-related harm. Although DCRs have been established globally, they are perceived by some to be a controversial approach in the UK, and Government has repeatedly rejected proposals to establish one in Glasgow, Scotland. As public support is an important component of policy development and enactment, we sought to investigate the effects of different types of message framing on public support for DCR. METHODS We undertook a cross-sectional online study with a randomised design, conducted with a nationally representative sample. Participants were randomised to one of six message conditions comprising combinations of four components. All conditions included i) a basic description of a DCR, and conditions included combinations of ii) factual information; iii) pre-emptive refutation of common public concerns about DCR; and/or iv) a sympathetic narrative describing a mother whose son died from a heroin overdose. After reading each message, participants completed a bespoke measure assessing support for DCR. Data were analysed using ANCOVA. RESULTS Complete data were obtained from 1591 participants (50.3% Female; mean age 44.9 ± 16.1 years). Compared to reading a basic description of DCR alone, there was greater support for DCR in participants receiving the refutation (p < .001); sympathetic + factual (p < .05); and sympathetic + factual + refutation (p < .001) message conditions. Presenting factual or sympathetic messages alone were not associated with increased support. CONCLUSION Our findings suggest that public support for DCRs is not improved through communication of factual statements outlining potential benefits of the intervention alone. Advocates seeking to foster public support, and thus influence policy making, should also consider communication campaigns that address common concerns that the public might have about DCRs, and present the intervention in relation to potential benefits that they hold for people indirectly affected by drug-related harm.
Collapse
Affiliation(s)
- H R Sumnall
- Public Health Institute, Liverpool John Moores University, Liverpool, UK.
| | - A M Atkinson
- Public Health Institute, Liverpool John Moores University, Liverpool, UK
| | - K M A Trayner
- School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Health Protection Scotland, Glasgow, UK
| | - S H Gage
- Psychological Sciences, University of Liverpool, UK
| | - A McAuley
- School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK; Health Protection Scotland, Glasgow, UK
| |
Collapse
|
27
|
Alves YDD, Pereira PPG, Peres PS. Nascimento, vida e morte de uma política pública: uma etnografia do programa De Braços Abertos. CAD SAUDE PUBLICA 2020; 36:e00213918. [DOI: 10.1590/0102-311x00213918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2018] [Accepted: 08/28/2019] [Indexed: 11/22/2022] Open
Abstract
Resumo: Políticas públicas direcionadas à Cracolândia (São Paulo, Brasil) vêm sendo implementadas há décadas e carecem de uma descrição abrangente. Realizamos este estudo pela importância e caráter inovador do programa De Braços Abertos (DBA), com o propósito de oferecer um quadro compreensivo desde seu início até o encerramento. Isso por meio: (i) do levantamento das atividades desenvolvidas por agentes públicos que precederam o Programa e que influenciaram diretamente a sua formulação; (ii) da descrição do estado em que se encontrava a Cracolândia no momento de implantação do DBA; (iii) da especificação dos atores institucionais e suas atribuições; e (iv) da exposição dos principais acontecimentos que marcaram o desenvolvimento dessa política pública até sua extinção. Para tanto, nos valemos de nossa vivência etnográfica na Cracolândia, que pôde ser cotejada com uma parcela importante do material bibliográfico existente sobre o tema. Identificamos uma forte influência do trabalho pregresso de profissionais, principalmente do campo da Saúde Mental do município na concepção e desenvolvimento do DBA, mas que, no entanto, aconteceu com a participação ativa de diversos entes, com importante caráter intersecretarial. A pesquisa mostrou a relação íntima e adaptativa entre o Programa e o ambiente da Cracolândia, assim como os conflitos com o crime organizado e as polícias que fomentaram o desenvolvimento de competências específicas por parte dos agentes do município. Ao ser desmantelado, o Programa deixou uma importante herança no surgimento de uma militância em prol dos direitos recém-adquiridos pelos usuários de crack, o que certamente poderá significar alguma resistência contra medidas do poder público.
Collapse
|
28
|
Kammersgaard T. Being 'in place', being 'out of place': Problematising marginalised drug users in two cities. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2019; 75:102589. [PMID: 31739150 DOI: 10.1016/j.drugpo.2019.10.014] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2019] [Revised: 10/05/2019] [Accepted: 10/29/2019] [Indexed: 12/01/2022]
Abstract
BACKGROUND Socially marginalised drug users when congregating in the public space on so-called 'open drug scenes' are often problematised, especially in post-industrial cities which increasingly are engaged in attempts to attract those that are considered to be promoters of economic activity through processes of 'beautification' and 'gentrification'. The different punitive practices that target homeless and marginalised drug users in the public space have been rendered visible in a range of influential accounts since the 1990s. However, these accounts have mostly been based on the US context and it has been argued that, in a European context, responses from local governments have been more variegated and ambivalent. METHODS Two case studies of the response to homeless and marginalised drug users in public space were investigated in the two major cities of Denmark, Aarhus and Copenhagen. In order to account for the differences in responses to marginalised drug users between the two cases, the different problematisations of their presence were investigated through document analysis and interviews with key stakeholders. RESULTS The marginalised drug users were seen as 'out of place' in the open drug scene in Aarhus, while the marginalised drug users in the open drug scene in Copenhagen repeatedly were discursively constructed as being 'in place' and having a historical 'right' to be in this particular neighbourhood. CONCLUSION The study illustrates that, by using the concept of 'problematisation', it is possible to reveal the assumptions about the proper use of the public space that underlies responses to the presence of marginalised drug users. Comparisons of such problematisations render us able to see how similar issues of marginalised drug users and the use of the public space can be problematised differently in different urban spaces and how this can legitimise specific governmental responses.
Collapse
Affiliation(s)
- Tobias Kammersgaard
- Centre for Alcohol and Drug Research, Aarhus University, Artillerivej 90, 2, 2300 Copenhagen, Denmark.
| |
Collapse
|
29
|
Smith P, Favril L, Delhauteur D, Vander Laenen F, Nicaise P. How to overcome political and legal barriers to the implementation of a drug consumption room: an application of the policy agenda framework to the Belgian situation. Addict Sci Clin Pract 2019; 14:40. [PMID: 31672169 PMCID: PMC6823966 DOI: 10.1186/s13722-019-0169-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2019] [Accepted: 10/10/2019] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND For more than 30 years, drug consumption rooms (DCRs) have been implemented in Western countries. DCRs are supported by a large body of evidence about public safety and public health effectiveness. However, a political consensus has never been achieved in Belgium on amending the existing law that explicitly penalises the supply of a room for facilitating drug use. Despite this adverse legal and policy framework, a DCR opened in the city of Liège in 2018. In this case report, we applied the theoretical framework proposed by Shiffman and Smith for policy agenda setting, in order to describe and assess how political and legal barriers were overcome in the process of opening the DCR. CASE PRESENTATION For some years, fieldworkers and some city policymakers argued for DCR implementation in Belgium, but without gaining the support of the national authorities, mainly for ideological reasons. In order to address this debate, a feasibility study of DCR implementation in Belgian cities was commissioned. At the national level, an institutional debate took place about the political responsibility for DCRs as a public health intervention, as health care is mainly a matter of regional policy. The lack of consensus led to a situation of political deadlock. Meanwhile, the publication of the study report and the context of local elections offered an opportunity for Liège authorities to reignite the local debate on DCRs. At the local level, law enforcement, care professionals, residents, users, and the press were all involved in the implementation process. Therefore, a local consensus was formed and despite the absence of any national legal change, the DCR opened 1 month before the local elections. It has been working without major medical or legal incident since then. Incidentally, the mayor of Liège was re-elected. CONCLUSIONS Although the lack of a legal framework may engender instability and affect longer-term effectiveness, the DCR implementation in Liège was successful and was based on a local consensus and effective communication rather than on an appropriate legal framework. The experience provides lessons for other cities that are considering opening a DCR despite an adverse legal and political context.
Collapse
Affiliation(s)
- Pierre Smith
- Institute of Health and Society (IRSS), Université Catholique de Louvain, Clos Chapelle-aux-Champs, 30, 1200, Brussels, Belgium.
| | - Louis Favril
- Institute for International Research on Criminal Policy (IRCP), Faculty of Law and Criminology, Ghent University, Ghent, Belgium
| | | | - Freya Vander Laenen
- Institute for International Research on Criminal Policy (IRCP), Faculty of Law and Criminology, Ghent University, Ghent, Belgium
| | - Pablo Nicaise
- Institute of Health and Society (IRSS), Université Catholique de Louvain, Clos Chapelle-aux-Champs, 30, 1200, Brussels, Belgium
| |
Collapse
|
30
|
‘We are still obsessed by this idea of abstinence’: A critical analysis of UK news media representations of proposals to introduce drug consumption rooms in Glasgow, UK. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2019; 68:62-74. [DOI: 10.1016/j.drugpo.2019.03.010] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2018] [Revised: 12/19/2018] [Accepted: 03/01/2019] [Indexed: 01/15/2023]
|
31
|
Struggling to achieve a 'normal life': A qualitative study of Vietnamese methadone patients. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2019; 68:18-26. [PMID: 30978641 DOI: 10.1016/j.drugpo.2019.03.026] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2018] [Revised: 02/27/2019] [Accepted: 03/11/2019] [Indexed: 02/07/2023]
Abstract
BACKGROUND Methadone maintenance treatment, initially introduced in Vietnam for HIV harm reduction, has marked a significant switch in the country's drug policy - from addiction as a moral issue to addiction as a brain disease. After the some initial outstanding achievements, the programme is facing a high dropout rate that threatens both goals of HIV prevention and drug treatment. This sociological study, as part of an HIV intervention research project, explores the challenges and opportunities that individuals who use drugs are faced with in relation to addiction treatment. METHODS A qualitative study among drug users with and without methadone maintenance treatment experiences recruited by peer outreach workers. We conducted 58 in-depth interviews and 2 focus groups between 2016 and 2017. RESULTS The start of treatment brought about significant feelings of success as heroin use was no longer compulsive. However, being in treatment programmes is also challenging with respect to continuing the recovery process. Barriers to retention include a popular fear of methadone as another harmful drug, a feeling of dependence related to the current practices of methadone treatment programmes and a poor therapeutic relationship. In the face of such challenges, the two major motivations that keep patients in care come from the desire to completely break up with heroin and the pursuit of family happiness. CONCLUSION The current practices of methadone programmes pose challenges to patients' recovery efforts from addiction and threaten treatment retention. Prompt interventions are needed to help Vietnam attain its objective of providing better care for larger vulnerable populations.
Collapse
|
32
|
Auriacombe M, Roux P, Briand Madrid L, Kirchherr S, Kervran C, Chauvin C, Gutowski M, Denis C, Carrieri MP, Lalanne L, Jauffret-Roustide M. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. BMJ Open 2019; 9:e023683. [PMID: 30796121 PMCID: PMC6398695 DOI: 10.1136/bmjopen-2018-023683] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/18/2018] [Revised: 12/27/2018] [Accepted: 01/04/2019] [Indexed: 12/31/2022] Open
Abstract
INTRODUCTION The high prevalence of hepatitis C and the persistence of HIV and hepatitis C virus (HCV) risk practices in people who inject drugs (PWID) in France underlines the need for innovative prevention interventions. The main objective of this article is to describe the design of the COSINUS cohort study and outline the issues it will explore to evaluate the impact of drug consumption rooms (DCR) on PWID outcomes. Secondary objectives are to assess how DCR (a) influence other drug-related practices, such as the transition from intravenous to less risky modes of use, (b) reduce drug use frequency/quantity, (c) increase access to treatment for addiction and comorbidities (infectious, psychiatric and other), (d) improve social conditions and (e) reduce levels of violence experienced and drug-related offences. COSINUS will also give us the opportunity to investigate the impact of other harm reduction tools in France and their combined effect with DCR on reducing HIV-HCV risk practices. Furthermore, we will be better able to identify PWID needs. METHODS AND ANALYSIS Enrollment in this prospective multi-site cohort study started in June 2016. Overall, 680 PWID in four different cities (Bordeaux, Marseilles, Paris and Strasbourg) will be enrolled and followed up for 12 months through face-to-face structured interviews administered by trained staff to all eligible participants at baseline (M0), 3 month (M3), 6 month (M6) and 12 month (M12) follow-up visits. These interviews gather data on socio-demographic characteristics, past and current drug and alcohol consumption, drug-use related practices, access to care and social services, experience of violence (as victims), offences, other psychosocial issues and perception and needs about harm reduction interventions and services. Longitudinal data analysis will use a mixed logistic model to assess the impact of individual and structural factors, including DCR attendance and exposure to other harm reduction services, on the main outcome (HIV-HCV risk practices). ETHICS AND DISSEMINATION This study was reviewed and approved by the institutional review board of the French Institute of Medical Research and Health (opinion number: 14-166). The findings of this cohort study will help to assess the impact of DCR on HIV-HCV risk practices and other psycho-social outcomes and trajectories. Moreover, they will enable health authorities to shape health and harm reduction policies according to PWID needs. Finally, they will also help to improve current harm reduction and therapeutic interventions and to create novel ones.
Collapse
Affiliation(s)
- Marc Auriacombe
- University of Bordeaux, Bordeaux, Aquitaine, France
- Addiction Team, SANPSY, CNRS USR 3413, Bordeaux, France
- Department of Psychiatry, University of Pennsylvania Center for Studies of Addiction, Philadelphia, Pennsylvania, USA
- Pôle Addictologie, CH Charles Perrens and CHU de Bordeaux, Bordeaux, France
| | - Perrine Roux
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, Marseille, France
- ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d’Azur, Marseille, France
| | - Laélia Briand Madrid
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, Marseille, France
- ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d’Azur, Marseille, France
| | - Sébastien Kirchherr
- Department of Psychiatry and Addictology, INSERM 1114, University Hospital of Strasbourg, Strasbourg, France
| | - Charlotte Kervran
- University of Bordeaux, Bordeaux, Aquitaine, France
- Addiction Team, SANPSY, CNRS USR 3413, Bordeaux, France
| | - Carole Chauvin
- CERMES3 (INSERM U988/UMR CNRS 8211/EHESS/Paris Descartes University), Paris, France
| | - Marie Gutowski
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, Marseille, France
- ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d’Azur, Marseille, France
| | - Cécile Denis
- Addiction Team, SANPSY, CNRS USR 3413, Bordeaux, France
- Department of Psychiatry, University of Pennsylvania Center for Studies of Addiction, Philadelphia, Pennsylvania, USA
| | - Maria Patrizia Carrieri
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, Marseille, France
- ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d’Azur, Marseille, France
| | - Laurence Lalanne
- INSERM U1114, Strasbourg, Alsace, France
- Department of Psychiatry and Addictology, Hopitaux universitaires de Strasbourg, Strasbourg, France
| | | | | |
Collapse
|
33
|
Cleirec G, Fortias M, Bloch V, Clergue-Duval V, Bellivier F, Dusouchet T, Debaulieu C, Vorspan F. Opinion of health professionals and drug users before the forthcoming opening of the first drug consumption room in Paris: a quantitative cross-sectional study. Harm Reduct J 2018; 15:53. [PMID: 30359272 PMCID: PMC6202864 DOI: 10.1186/s12954-018-0260-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Accepted: 10/17/2018] [Indexed: 12/16/2022] Open
Abstract
Background On the brink of the opening of the first French drug consumption room in Paris, the general opinion of the local involved health care professionals and drug users was not known. The objective of this study was to determine their expectations and to search for influencing factors. Method We carried out a quantitative cross-sectional study. A multiple choice questionnaire was proposed to the surrounding willing general practitioners (GPs) and pharmacists, to the emergency doctors of Lariboisière hospital, and to the professionals of the harm reduction facilities and their drug users (PWUD). For each question, there was a choice between seven answers, from “− 3” (very negative impact) to “+ 3” (very positive impact). The influence of the characteristics of each group on its mean answers was explored by Mann-Whitney, Kruskal-Wallis, and Spearman’s tests. Results The median expectations among the groups of responding GPs (N = 62), other health care professionals (N = 82), and PWUD (N = 57) were mainly positive. They thought that the drug consumption room (DCR) would improve the health of PWUD, reduce their at-risk behaviors, would not increase drug use or drug dealing in the neighborhood, and would reduce nuisance in the public space. Only the group of GPs expressed that the DCR could decrease the quietness of the neighborhood, and only the group of PWUD had higher expectations that the DCR would decrease the number of arrests and the number of violent behavior. GPs’ expectations were significantly better in terms of health improvement of PWUD and reducing their precariousness if they had a previous experience in addiction medicine (Mann-Whitney, p = 0.004 and p = 0.019), with a longer practice (Spearman’s rho, p = 0.021 and p = 0.009), and if they were currently prescribing opioid substitution treatments (Mann-Whitney, p = 0.030 and p = 0.002). Among non-GPs, those who were working in addiction medicine centers had significantly better expectations than pharmacists, and the professionals of the local emergency department had intermediate expectations. Conclusions Health care professionals and drug users had a positive opinion of the to-be-created Parisian drug consumption room. Experience in addiction medicine influenced positively health professionals’ expectations.
Collapse
Affiliation(s)
- Grégoire Cleirec
- Service de médecine addictologique, Hôpital René Muret, APHP, Sevran, France
| | - Maeva Fortias
- Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France
| | - Vanessa Bloch
- Inserm Umrs1144 Variabilité de Réponse aux Psychotropes, Paris, France
| | - Virgile Clergue-Duval
- Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.,Faculté de Médecine, Université Paris Diderot, Paris, France.,Inserm Umrs1144 Variabilité de Réponse aux Psychotropes, Paris, France
| | - Frank Bellivier
- Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France.,Faculté de Médecine, Université Paris Diderot, Paris, France.,Inserm Umrs1144 Variabilité de Réponse aux Psychotropes, Paris, France
| | | | | | - Florence Vorspan
- Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, APHP, Paris, France. .,Faculté de Médecine, Université Paris Diderot, Paris, France. .,Inserm Umrs1144 Variabilité de Réponse aux Psychotropes, Paris, France.
| |
Collapse
|
34
|
Houborg E, Bjerge B, Frank VA. Editorial: Comparing drug policies. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2018; 56:128-130. [PMID: 29861169 DOI: 10.1016/j.drugpo.2018.05.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|